- $4.31bn
- $5.58bn
- $1.85bn
Integer Holdings beats Q2 sales estimates, raises FY foreacst
Brief: Integer Outlook FY Revenue USD 1,850-1,876 Million
Integer Holdings Corp reports results for the quarter ended March 31 - Earnings Summary
Brief: Integer Announces CEO Succession Plan
Brief: Integer Holdings Corporation Issues Statement On Tariffs
U.S. STOCKS ON THE MOVE-Washington Trust, Centessa Pharma, Kingstone
U.S. STOCKS ON THE MOVE-ANI Pharma, Ulta Beauty, KeyCorp
Integer down after upsized $875 million convertible debt offering
Brief: Integer Holdings Corp Prices $875 Million Convertible Senior Notes Due 2030
Integer launches $750 mln convertible debt deal; shares unchanged post-market
Integer falls after forecasting 2025 profit below estimates
Integer Holdings Corp reports results for the quarter ended December 31 - Earnings Summary
Brief: Integer Holdings Corporation Announces Conversion Period For 2.125% Convertible Senior Notes Due 2028
Brief: Integer Holdings Corporation Completes Divestiture Of Non-Medical Business For $50 Mln
Brief: Ultralife Corporation Completes Acquisition Of Electrochem Solutions, Inc.
Integer Holdings Corp reports results for the quarter ended in September 30 - Earnings Summary
Integer Holdings Corp expected to post earnings of $1.36 a share - Earnings Preview
Brief: Ultralife Corporation To Acquire Electrochem Solutions
Brief: Integer Holdings To Divest Non-Medical Business For $50 Million